"Real-World" use of cinacalcet for managing SHPT in different European countries: analysis of data from the ECHO observational study
Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › fagfællebedømt
The pan-European ECHO observational study evaluated cinacalcet in adult dialysis patients with secondary hyperparathyroidism (SHPT) in "real-world" clinical practice. A sub-analysis compared data for 7 European countries/country clusters: Austria, CEE (Czech Republic and Slovakia), France, Italy, Netherlands, Nordics (Denmark, Finland, Norway, and Sweden), and the UK/Ireland.
Originalsprog | Engelsk |
---|---|
Tidsskrift | Clinical Nephrology |
Vol/bind | 74 |
Udgave nummer | 3 |
Sider (fra-til) | 198-208 |
Antal sider | 11 |
ISSN | 0301-0430 |
Status | Udgivet - 1 sep. 2010 |
ID: 34087952